医学
肺动脉高压
肺病
重症监护医学
疾病
临床实习
转化研究
肺
血管疾病
流行病学
心脏病学
内科学
病理
物理疗法
作者
Shelsey W. Johnson,Natascha Sommer,Katherine Cox,Norbert Weißmann,Corey E. Ventetuolo,Bradley A. Maron
标识
DOI:10.1164/rccm.202302-0327so
摘要
Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH) associated with lung disease, and chronic thromboembolic PH cast new light on the pathogenetic mechanisms, epidemiology, diagnostic approach, and therapeutic armamentarium for pulmonary vascular disease. Here, we summarize key basic, translational, and clinical PH reports, emphasizing findings that build on current state-of-the-art research. This review includes cutting-edge progress in translational pulmonary vascular biology, with a guide to the diagnosis of patients in clinical practice, incorporating recent PH definition revisions that continue emphasis on early detection of disease. PH management is reviewed including an overview of the evolving considerations for the approach to treatment of PH in patients with cardiopulmonary comorbidities, as well as a discussion of the groundbreaking sotatercept data for the treatment of pulmonary arterial hypertension.
科研通智能强力驱动
Strongly Powered by AbleSci AI